1. (a) The postnatal donation initiative must include the dissemination of the following information:

   1. (1) Information concerning the option that is available to pregnant women to make a postnatal donation upon the birth of a newborn infant.

   2. (2) An explanation of the benefits and risks of using postnatal fluid and postnatal tissue in accordance with the National Marrow Donor Program or another federal Food and Drug Administration approved protocol, and the use of postnatal fluid and postnatal tissue for medical treatment, including the following:

      1. (A) A list of the diseases or conditions that have been treated through the use of postnatal donations.
      2. (B) A list of the diseases or conditions for which scientific research indicates that treatment through the use of postnatal donations are promising.
   3. (3) Information concerning the process by which postnatal fluid and postnatal tissue are collected and the steps that a pregnant woman must take to arrange to have the postnatal fluid or postnatal tissue, or both, collected and donated.

2. (b) The state department shall:

   1. (1) update the material described in subsection (a); and

   2. (2) provide for the distribution of the information to at least the following persons that treat pregnant women:

      1. (A) Physicians licensed under IC 25-22.5 .
      2. (B) Health care facilities.
      3. (C) Ambulatory surgical centers.
      4. (D) Health clinics.
      5. (E) Maternity homes registered under IC 16-26-1 .
      6. (F) Nurse midwives licensed under IC 25-23-1-13.1 .
      7. (G) Birthing centers licensed under IC 16-21-2 .

3. (c) A person described in subsection (b)(2) shall provide the information distributed under subsection (b) to women who:

   1. (1) are pregnant and receive prenatal services from the person; or
   2. (2) give birth at the person's facility.

As added by P.L.138-2014, SEC.8. Amended by P.L.48-2016, SEC.1.